O ver the last decade, clinical research has demonstrated that a restrictive strategy for the transfusion of red blood cells (RBC) should be used for critically ill patients who are not hemorrhaging or experiencing active cardiac ischemia. Specifically, a large multicentered randomized study, the Transfusion Requirements in Critical Care (TRICC) trial, found that transfusing for a hemoglobin Ͻ7 g/dL was at least as effective as a liberal strategy (transfusing for a hemoglobin Ͻ10 g/dL) when considering patient mortality (1) . Furthermore, RBC transfusion is associated with increased complications including nosocomial infections (2) (3) (4) (5) (6) and acute lung injury (ALI) (7) (8) (9) (10) (11) . Despite this research evidence, three large populationbased observational studies, conducted 1 to 3 years after the TRICC trial publication, demonstrated that mean transfusion thresholds (8.2-8.6 g/dL) remain above the level recommended by this trial (12) (13) (14) .
In patients with ALI, a restrictive transfusion strategy may be especially important. Liberal RBC transfusion does not improve ventilator-free days for mechanically ventilated patients (15) . Furthermore, each RBC unit transfused is independently associated with a 6% to 10% greater odds of death (16, 17) .
Understanding transfusion practices in patients with ALI and the factors associated with variations in transfusion thresholds may help in developing strategies to improve evidence-based practice. Consequently, we sought to describe recent RBC transfusion practices in a cohort of patients with ALI and to evaluate what factors were associated with the pretransfusion hemoglobin concentration in those patients receiving a transfusion in the intensive care unit (ICU) after ALI onset.
MATERIALS AND METHODS
Study Setting. Nine ICUs (three medical, four surgical, and two trauma) at three teaching hospitals in Baltimore, MD provided data
Objective: To describe red blood cell (RBC) transfusion practices and evaluate the association between patient-related factors and pretransfusion hemoglobin concentration in acute lung injury (ALI).
Design: Secondary analysis of prospectively collected data. Setting: Nine intensive care units (ICUs) in three teaching hospitals in Baltimore, MD.
Patients: Two hundred forty-nine consecutive patients with ALI requiring mechanical ventilation.
Interventions: None.
Measurements and Main Results:
Simple and multiple linear regression analyses were used to evaluate the association between the nadir hemoglobin concentration on the day of initial RBC transfusion and 20 patient-level demographic, clinical and ICU treatment factors as well as ICU type. Of 249 patients with ALI, 47% received an RBC transfusion in the ICU without evidence of active hemorrhage or acute cardiac ischemia. The mean (SD) nadir hemoglobin on the day of first transfusion was 7.7 (1.1) g/dL with 67%, 36%, 15%, and 5% of patients transfused at >7, >8, >9, and >10g/dL, respectively. Transfused patients received a mean (SD) of 5 (6) RBC units from ALI diagnosis to ICU discharge. Prehospital use of iron or erythropoietin and platelet transfusion in the ICU were independently associated with lower pretransfusion hemoglobin concentrations. No patient factors were associated with higher hemoglobin concentrations. Admission to a surgical (vs. medical) ICU was independently associated with a 0.6 g/dL (95% confidence interval 0.1-1.1 g/dL) higher pretransfusion hemoglobin.
Conclusions: Patients with ALI commonly receive RBC transfusions in the ICU. The pretransfusion hemoglobin observed in our study was lower than earlier studies, but a restrictive strategy was not universally adopted. for this analysis. All medical ICUs (MICUs) in the study have a dedicated ICU team solely responsible for patient care. All surgical ICUs (SICUs) use a comanagement model with all patients being managed by the dedicated ICU team as well as the patient's primary surgical team. RBC transfusions in the study ICUs are prescribed by a variety of clinicians (e.g., attending, fellow and resident physicians, and nurse practitioners). None of the ICUs have a written protocol for transfusion practices or routinely document the indication for transfusion when ordered.
Study Participants. Consecutive mechanically ventilated patients diagnosed with ALI using American-European Consensus Conference criteria (18) were enrolled from October 2004 to July 2006 (19) . Exclusion criteria for the cohort study included 1) pre-existing ALI for Ͼ24 hours before transfer to a study site ICU; 2) Ͼ5 days of mechanical ventilation before eligibility; 3) a limitation in care (e.g., no vasopressors) at eligibility; or 4) a preexisting condition with a life expectancy Ͻ6 months.
A convenience sample of 249 consecutive patients enrolled in the ongoing cohort study was used for this secondary data analysis. Consistent with the TRICC trial eligibility criteria, we excluded patients from the study cohort who had active blood loss (defined as a diagnosis of gastrointestinal bleeding or hemorrhagic shock at ICU admission, or transfusion of Ͼ3 RBC units on the day of first transfusion) or acute cardiac disease (defined as a diagnosis of acute myocardial ischemia at ICU admission or an elevated troponin on the day of first transfusion) (1) .
Outcome. The primary outcome of this study was the nadir hemoglobin concentration (g/dL) on the day of first RBC transfusion in the ICU after ALI diagnosis.
Exposures. Based on published literature and expert opinion, we prospectively collected data on patient characteristics potentially associated with RBC transfusion (1, 12, 14, 16, 17, 20, 21) . In addition to demographic data (age, sex, and race), 11 clinical characteristics were measured: comorbid conditions (Charlson comorbidity index [22] and cardiac disease), routine prehospital use of medications that may influence hematopoiesis (iron, erythropoietin, folate, and vitamin B 12 ), primary ICU admitting diagnosis, severity of illness at ICU admission (Acute Physiologic and Chronic Health Evaluation II score [23] ), ALI risk factor, severity of lung injury at ALI onset (Lung Injury Score, calculated based on chest radiograph, hypoxemia, and positive end-expiratory pressure data [24] ), and organ dysfunction on the day of transfusion (Sequential Organ Failure Assessment) (25) .
Additionally, six exposure variables related to a patient's ICU course were evaluated: ICU admission source (emergency department or ward at the study site hospital or transfer from an outside hospital) and potentially relevant ICU interventions occurring from ALI onset through the day of first RBC transfusion (platelet transfusion, iron administration, erythropoietin administration, continuous hemodialysis, and intermittent hemodialysis). Finally, ICU type (MICU or SICU) was evaluated as an organizational factor potentially associated with transfusion practices.
Statistical Analyses. Descriptive statistics were reported using mean (SD) for continuous data and proportions for categorical data. Continuous and categorical data were compared using the Student's t test and chi-square test, respectively. Exposures were modeled based on the published literature. When such information was not available, we examined a scatterplot of the exposure and outcome variable using a locally weighted LOWESS regression to determine appropriate modeling of the exposure (26) .
Simple linear regression was used to evaluate the association of each exposure variable with the nadir hemoglobin on the day of RBC transfusion. Exposures with an association of p Յ 0.15 were included in a subsequent multiple linear regression model. This analysis adjusted for potential clustering of outcome data within each hospital (i.e., hospitalspecific effect on transfusion practices) using a fixed effects model with robust variance estimation. Variance inflation factors were used to confirm that co-linearity was not present among exposure variables in the final model. Diagnostic plots (e.g., residual vs. fitted values) were used to confirm that the final model did not violate any assumptions required for linear regression.
All analyses were performed using STATA version 10.0 (College Station, TX). A two-sided p Ͻ 0.05 was used to determine statistical significance. The Institutional Review Boards at the Johns Hopkins School of Medicine and all participating sites approved the study.
RESULTS
Patient Characteristics.Of the 249 patients enrolled in the cohort study, 117 (47%) received an RBC transfusion without an evidence of active blood loss or acute cardiac disease ( Fig. 1 ). Only one such patient received care in a trauma ICU and, for the purposes of this analysis, was categorized with SICU patients at the same hospital. The characteristics of these transfused patients are summarized in Table 1 . The mean (SD) age was 54 (16) years and comorbid cardiac disease was documented in 18% of patients. Pulmonary diagnoses (including pneumonia) accounted for 57% of ICU admitting diagnoses. ALI was attributed to pulmonary risk factors (e.g., aspiration and pneumonia) for 48% of patients. Most patients (79%) were admitted to an MICU.
Transfusion Practices.The mean (SD) nadir hemoglobin on the day of first transfusion was 7.7 (1.1) g/dL, with 67%, 36%, 15%, and 5% of patients transfused for a nadir hemoglobin Ն7, Ն8, Ն9, and Ն10 g/dL, respectively (Fig. 2 ). The mean (SD) time to first transfusion after ALI diagnosis was 3 (5) days with 41%, 48%, and 11%, of patients receiving 1, 2, and 3 RBC units on this day, respectively. From ALI diagnosis to ICU discharge, each patient received an average (SD) of 5 (6) RBC units.
Factors Associated with Pretransfusion Hemoglobin Concentration. Nine exposure variables were associated (p Յ 0.15) with the mean nadir hemoglobin concentration on the day of first RBC transfusion using simple linear regression ( Table 2 ). Higher mean nadir hemo- globin concentrations were associated with age, white race, gastrointestinal primary ICU admitting diagnosis, and SICU admission. Five factors were associated with a lower mean nadir hemoglobin concentration: higher Charlson comorbidity index, routine use of iron before hospital admission, routine use of erythropoietin before hospital admission, greater Lung Injury Score, and platelet transfusion in the ICU. The nine variables crudely associated with pretransfusion hemoglobin concentration were evaluated in the multiple linear regression model (Table 3 ). This analysis demonstrated that three patientrelated factors were independently associated with lower pretransfusion hemoglobin concentrations. Routine iron use before hospitalization, routine erythropoietin use before hospitalization, and platelet transfusion in the ICU were associated with 0.5 g/dL (95% confidence interval Ϫ0.1 to 1.0 g/dL), 0.8 (0.3-1.4) g/dL, and 0.5 (0.005-0.9) g/dL lower pretransfusion hemoglobin concentrations, respectively. No patient-related factors were significantly associated with a higher hemoglobin concentration. ICU type was a significant factor, with patients admitted to a SICU being transfused at a mean nadir hemoglobin concentration 0.6 g/dL (95% confidence interval 0.1-1.1 g/dL) higher than patients admitted to an MICU.
DISCUSSION
In this prospective cohort study of 249 patients with ALI, 47% received an RBC transfusion in the ICU without evidence of active hemorrhage or acute cardiac ischemia. Transfused patients received an average of 5 RBC units in the ICU. The mean nadir hemoglobin on the day of first transfusion of 7.7 g/dL with 15% of patients transfused at a hemoglobin concentration Ն9 g/dL. Despite evaluating 20 patient-related factors, none were independently associated with a higher pretransfusion hemoglobin concentration. However, admission to an SICU (vs. MICU) was independently associated with a 0.6g/dL higher pretransfusion hemoglobin.
The transfusion practices we observed can be compared with several prior studies. Our observed frequency of transfusion and mean number of RBC units transfused seem similar to other observational studies of general ICU patients (4, (12) (13) (14) 27) . Gong et al (16) reported more frequent transfusions with acute respira- Two prior publications observed a pretransfusion hemoglobin concentration similar to our study (7.6 and 7.8 g/dL, respectively) (4, 28) . This transfusion threshold is lower than earlier observations by Vincent et al (8.5 g/dL) and Corwin et al (8.6 g/dL) (12, 14) . Furthermore, a recent multicentered randomized trial demonstrated mean pretransfusion hemoglobin concentrations of 8.0 and 8.2 g/dL in the placebo and epoetin alfa groups, respectively (29) . Hence, clinical practice seems to be moving toward a more restrictive transfusion strategy since publication of the TRICC trial in 1999 (29) .
Literature examining the relationship between patient-related factors and transfusion practices is limited. In a survey of Canadian critical care physicians, Hébert et al (20) presented a variety of clinical scenarios and inquired about clinicians' transfusion thresholds. They found significant associations between older patient age and a higher Acute Physiologic and Chronic Health Evaluation II score with selection of a transfusion threshold Ͼ7 g/dL. Although patient age had a positive association with transfusion threshold in our simple linear regression, it was not independently associated with nadir hemoglobin in our multiple regression model.
Our study did not identify patientrelated factors that would account for why two-thirds of patients with ALI but no evidence of active hemorrhage or acute cardiac ischemia are transfused above the threshold recommended by clinical trial evidence. We did observe that prehospital iron or erythropoietin use and platelet transfusion in the ICU were associated with a lower pretransfusion hemoglobin concentration. We believe that these factors may be markers for a subset of patients with some element of bone marrow suppression in whom clinicians are willing to tolerate a greater degree of anemia before RBC transfusion. Future research is required to confirm this hypothesis and understand if pancytopenia is an important factor in the RBC threshold in transfused patients.
Interestingly, our study observed that the pretransfusion hemoglobin concentration was associated with the type of ICU (SICU vs. MICU) in which a patient received care. This finding was present after excluding patients with potential bleeding as the cause of transfusion and is independent of the 20 factors related to patients' demographics, clinical characteristics, and ICU course. The observed difference may reflect provider and/or organizational factors influencing transfusion practices, such as the different ICU physician staffing models in SICUs vs. MICUs at our study site hospitals. Alternatively, as with all observational research, our finding may also be influenced by residual or unmeasured confounding by patient-related factors (e.g., incompletely excluding bleeding patients). Still, in their survey of transfusion practices, Hébert et al (20) found that physicians spending a greater proportion of clinical time in the ICU were more likely to chose a restrictive transfusion threshold. Hence, perhaps systematic differences in provider knowledge, attitudes, or beliefs (30) regarding the risks and benefits of RBC transfusions in SICUs vs. MICUs may be the underlying explanation for this finding.
Although studies have reported the benefit of instituting policies and protocols on evidence-based transfusion practices (31, 32) , it seems that many U.S. hospitals, including those participating in our study, have not yet adopted such relatively simple quality improvement strategies (33) . Future research should further explore barriers and related solutions for improving evidence-based transfusion practice and the potential influ- a Mean change in nadir hemoglobin concentration on day of first red blood cell transfusion associated with each 1 unit increase in continuous exposure variables (e.g., age) or each categorical exposure variable (e.g., comorbid cardiac disease) vs. its reference category as calculated using simple linear regression; b proportion of patients receiving the ICU intervention at any time from the day of ALI onset through the day of first red blood cell transfusion. ence of physician and ICU organizational factors (e.g., transfusion protocols and clinician level of training) on transfusion practices and patient outcomes. Specifically, study designs that use qualitative or mixed methods may be helpful to understand clinician attitudes and beliefs regarding transfusion thresholds.
There are potential limitations in our study. First, we determined the pretransfusion hemoglobin based on the nadir hemoglobin on the day of first transfusion. This approach may bias our pretransfusion hemoglobin concentration to be lower than the actual value prompting transfusion in these patients, thus inflating our observed compliance with a restrictive transfusion strategy. Second, by restricting our analysis to the subset of patients who received an RBC transfusion, we could not evaluate factors relevant to the decision regarding whether or not to transfuse a patient. Third, we did not examine the effect of these transfusions on patient outcomes such as mortality. Future studies with greater statistical power and different analytical methodologies will be needed to evaluate patient outcomes. Finally, although this study captures data from nine ICUs at three different hospitals, generalization of our findings to patient populations without ALI, other geographic regions, or nonacademic medical centers may be limited. However, because the transfu-sion practices we observed were similar to large studies of general ICU patient populations from both academic and community hospitals across United States and Europe, this limitation may be minimized.
CONCLUSION
Approximately half of patients with ALI, without bleeding or cardiac ischemia, receive an RBC transfusion in the ICU. The observed mean pretransfusion hemoglobin concentration of 7.7 g/dL is lower than earlier studies, but two-thirds of patients were still transfused above the 7.0 g/dL target hemoglobin concentration suggested by the TRICC trial. Patient factors do not seem to explain this gap between clinical trial evidence and routine practice. Patients admitted to an SICUs were transfused at a hemoglobin concentration 0.6 g/dL higher than otherwise similar patients admitted to MICUs, suggesting that physician behavior or ICU organizational factors may be a greater determinant of the transfusion threshold than patient-related variables. Table 2 which were associated with a change in mean nadir hemoglobin on the day of first transfusion at p Յ 0.15; b mean change in nadir hemoglobin concentration on day of first red blood cell transfusion associated with each 1 unit increase in continuous exposure variables (e.g., age) or each categorical exposure variable (e.g., routine iron use before hospitalization) as calculated using multiple linear regression with a fixed effect to account for clustering of the data within the 3 participating hospitals; c proportion of patients receiving the ICU intervention at any time from the day of ALI onset through the day of first red blood cell transfusion.
